Akron Biotechnology, LLC Awarded SBIR Grant For Development Of Novel Method To Isolate Adipose Derived Stem Cells
4/14/2014 9:39:31 AM
BOCA RATON, Fla.--(BUSINESS WIRE)--Akron Biotech, an innovative biotech company focused on serving the growing demands of the cell therapy industry, is pleased to announce it was awarded a Phase 1 Small Business Innovative Research (SBIR) Award from the National Institutes of Health (NIH) to develop enzyme-based formulations for the isolation of stem cells from various tissues. The project is in collaboration with Dr. Gregg Fields, Vice President of Scientific Affairs at Torrey Pines Institute for Molecular Studies, and will involve the use of novel engineered enzyme formulations to improve viability and quality of isolated stem cells with no toxicities.
Help employers find you! Check out all the jobs and post your resume.
comments powered by